EBITDA Summary of PharmaEngine, Inc.

PharmaEngine, Inc.'s latest annual EBITDA in 2023 was 347.3 Million TWD , down -28.66% from previous year.
PharmaEngine, Inc.'s latest quarterly EBITDA in 2024 Q2 was 146.01 Million TWD , up 62.74% from previous quarter.
PharmaEngine, Inc. reported an annual EBITDA of 401.15 Million TWD in 2022, down -27.8% from previous year.
PharmaEngine, Inc. reported an annual EBITDA of 555.87 Million TWD in 2021, down -27.41% from previous year.
PharmaEngine, Inc. reported a quarterly EBITDA of 105.09 Million TWD for 2024 Q1, up 67.95% from previous quarter.
PharmaEngine, Inc. reported a quarterly EBITDA of 105.38 Million TWD for 2023 Q3, up 41.37% from previous quarter.

Annual EBITDA Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual EBITDA of PharmaEngine, Inc. (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	347.3 Million TWD	-28.66%
2022	401.15 Million TWD	-27.8%
2021	555.87 Million TWD	-27.41%
2020	765.47 Million TWD	1255.16%
2019	56.48 Million TWD	24.51%
2018	166.7 Million TWD	-92.64%
2017	616.01 Million TWD	-24.05%
2016	811.11 Million TWD	146.57%
2015	328.96 Million TWD	364.45%
2014	70.82 Million TWD	150.9%
2013	-139.14 Million TWD	-377.39%
2012	50.06 Million TWD	-80.9%
2011	262.6 Million TWD	664.38%
2010	-46.53 Million TWD	51.88%
2009	-96.69 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	146.01 Million TWD	62.74%
2024 Q1	105.09 Million TWD	67.95%
2023 Q3	105.38 Million TWD	41.37%
2023 Q4	67.42 Million TWD	-36.02%
2023 FY	- TWD	-28.66%
2023 Q1	104.79 Million TWD	57.32%
2023 Q2	74.55 Million TWD	-28.86%
2022 Q1	124.33 Million TWD	-12.12%
2022 Q2	106.4 Million TWD	-14.43%
2022 Q3	103.81 Million TWD	-2.43%
2022 Q4	66.61 Million TWD	-35.83%
2022 FY	- TWD	-27.8%
2021 Q1	97.25 Million TWD	-85.22%
2021 Q2	211.44 Million TWD	117.4%
2021 Q3	105.46 Million TWD	-50.12%
2021 Q4	141.49 Million TWD	34.17%
2021 FY	- TWD	-27.41%
2020 Q3	27.7 Million TWD	84.63%
2020 Q2	15 Million TWD	-76.81%
2020 FY	- TWD	1255.16%
2020 Q1	64.68 Million TWD	249.01%
2020 Q4	658.08 Million TWD	2275.77%
2019 Q3	31.03 Million TWD	-5.8%
2019 FY	- TWD	24.51%
2019 Q4	-43.41 Million TWD	-239.88%
2019 Q2	32.94 Million TWD	-8.27%
2019 Q1	35.91 Million TWD	173.5%
2018 Q2	-10.09 Million TWD	64.43%
2018 Q3	70.69 Million TWD	800.54%
2018 FY	- TWD	-92.64%
2018 Q4	13.13 Million TWD	-81.43%
2018 Q1	-28.37 Million TWD	-104.14%
2017 Q1	-36.12 Million TWD	-105.31%
2017 Q3	-4.23 Million TWD	85.0%
2017 Q2	-28.21 Million TWD	21.91%
2017 Q4	684.58 Million TWD	16276.39%
2017 FY	- TWD	-24.05%
2016 FY	- TWD	146.57%
2016 Q4	680.86 Million TWD	977.28%
2016 Q3	-77.61 Million TWD	-132.24%
2016 Q2	240.7 Million TWD	832.93%
2016 Q1	-32.84 Million TWD	28.01%
2015 FY	- TWD	364.45%
2015 Q4	-45.61 Million TWD	-24.09%
2015 Q3	-36.76 Million TWD	-108.33%
2015 Q2	441.11 Million TWD	1581.4%
2015 Q1	-29.77 Million TWD	52.55%
2014 Q3	180.18 Million TWD	754.62%
2014 Q2	-27.52 Million TWD	-44.27%
2014 Q1	-19.07 Million TWD	36.31%
2014 FY	- TWD	150.9%
2014 Q4	-62.75 Million TWD	-134.83%
2013 Q3	-69.24 Million TWD	-229.54%
2013 Q1	-18.93 Million TWD	-11.03%
2013 Q2	-21.01 Million TWD	-10.95%
2013 Q4	-29.95 Million TWD	56.73%
2013 FY	- TWD	-377.39%
2012 Q3	-60.4 Million TWD	-397.78%
2012 Q4	-17.05 Million TWD	71.76%
2012 Q2	-12.13 Million TWD	-108.69%
2012 FY	- TWD	-80.9%
2012 Q1	139.7 Million TWD	776.21%
2011 Q2	266.87 Million TWD	1456.34%
2011 FY	- TWD	664.38%
2011 Q4	15.94 Million TWD	3080.19%
2011 Q1	-19.67 Million TWD	0.0%
2011 Q3	-535 Thousand TWD	-100.2%
2010 FY	- TWD	51.88%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of PharmaEngine, Inc.

Name	EBITDA	EBITDA Difference
Anti-Microbial Savior BioteQ Co., Ltd	-46.24 Million TWD	851.029%
SYN-TECH Chem. & Pharm. Co., Ltd.	393.6 Million TWD	11.763%
Level Biotechnology Inc.	98.7 Million TWD	-251.866%
Sagittarius Life Science Corp	-44.73 Million TWD	876.294%
NeoCore Technology Co., Ltd.	-72.11 Million TWD	581.6%
TaiMed Biologics Inc.	-25.23 Million TWD	1476.396%
GlycoNex Incorporation	-126.82 Million TWD	373.842%
VBI	-6.97 Million TWD	5081.44%
GeneReach Biotechnology Corp.	-143.69 Million TWD	341.697%
Taiwan Advance Bio-Pharmaceutical Inc.	21.81 Million TWD	-1492.416%
SynCore Biotechnology Co.,Ltd	-17.72 Million TWD	2059.303%
Genomics BioSci & Tech. Co.,Ltd.	-103.61 Million TWD	435.189%
Visgeneer Inc.	973 Thousand TWD	-35594.347%
Mycenax Biotech Inc.	-339.48 Million TWD	202.304%
Sunmax Biotechnology Co., Ltd.	936.46 Million TWD	62.913%
G&E Herbal Biotechnology Co., Ltd.	99.83 Million TWD	-247.873%
Neith Corporation	-33.61 Million TWD	1133.341%
Medigen Vaccine Biologics Corporation	-991.09 Million TWD	135.043%
TaiwanJ Pharmaceuticals Co., Ltd.	-1.73 Million TWD	20094.588%
Enimmune corporation	-228.96 Million TWD	251.687%
TaiRx, Inc.	-208.64 Million TWD	266.457%
CHO Pharma, Inc.	-277.73 Million TWD	225.051%
EirGenix Inc.	-664.4 Million TWD	152.273%
BioLASCO Taiwan Co., Ltd.	73.9 Million TWD	-369.942%
Sunny Pharmtech Inc.	69.14 Million TWD	-402.301%
Lin BioScience, Inc.	-1.07 Billion TWD	132.416%
BioGend Therapeutics Co., Ltd.	-113.1 Million TWD	407.062%
Feng Chi Biotech Corp.	34.83 Million TWD	-896.917%
Bio Preventive Medicine Corp.	-62.34 Million TWD	657.107%
Lukas Biomedical Inc.	-26.3 Million TWD	1420.555%
RBC Bioscience Corporation	36.54 Million TWD	-850.3%
BiOptic Inc.	65.03 Million TWD	-434.005%
BRIM Biotechnology, Inc.	-682.46 Million TWD	150.89%
Shine-On BioMedical Co.,Ltd.	-33 Million TWD	1152.251%
Great Novel Therapeutics Biotech & Medicals	-54.91 Million TWD	732.443%
Syngen Biotech Co.,Ltd.	433.55 Million TWD	19.894%
Advagene Biopharma Co., Ltd.	-80.07 Million TWD	533.742%
NaviFUS Corp.	-55.79 Million TWD	722.468%
Gwo Xi Stem Cell Applied Technology Co. , Ltd	-16.59 Million TWD	2192.457%
Sinew Pharma Inc.	-163.63 Million TWD	312.25%
Andros Pharmaceuticals Co.,Ltd	-61.5 Million TWD	664.725%
Greenyn Biotechnology Co., Ltd	192.4 Million TWD	-80.511%
Lumosa Therapeutics Co., Ltd.	-226.67 Million TWD	253.216%
AP Biosciences Inc	-325.51 Million TWD	206.695%
Medigen Biotechnology Corp.	-1.04 Billion TWD	133.247%
3D Global Biotech Inc.	-35.84 Million TWD	1068.884%
Pharmosa Biopharm Inc.	29.13 Million TWD	-1092.262%
Intech Biopharm Corporation	-219.58 Million TWD	258.165%
Oneness Biotech Co., Ltd.	-674.22 Million TWD	151.512%
Eusol Biotech Co.,Ltd.	-44.95 Million TWD	872.632%
TWi Biotechnology, Inc.	-160.85 Million TWD	315.91%
Ever Supreme Bio Technology Co., Ltd	655.52 Million TWD	47.018%
TCI GENE Inc.	25.98 Million TWD	-1236.769%
MegaPro Biomedical Co., Ltd	-110.63 Million TWD	413.912%
Senhwa Biosciences, Inc.	-283.78 Million TWD	222.383%
Taiwan Bio Therapeutics Co., Ltd	-145.97 Million TWD	337.93%
NatureWise Biotech & Medicals Corporation	13.85 Million TWD	-2407.625%
Savior Lifetec Corporation	219.6 Million TWD	-58.15%
TaiGen Biopharmaceuticals Holdings Limited	172.23 Million TWD	-101.652%
OBI Pharma, Inc.	-855.08 Million TWD	140.617%
Meribank Biotech Co., Ltd	-92.56 Million TWD	475.21%
Acepodia, Inc.	-764.51 Million TWD	145.428%
Caliway Biopharmaceuticals Co., Ltd.	-460.09 Million TWD	175.487%

Global Stocks Search

PharmaEngine, Inc. (4162.TWO)

EBITDA Summary of PharmaEngine, Inc.

Annual EBITDA Chart of PharmaEngine, Inc. (2023 - 2009)

Historical Annual EBITDA of PharmaEngine, Inc. (2023 - 2009)

Peer EBITDA Comparison of PharmaEngine, Inc.